992 related articles for article (PubMed ID: 26079779)
1. Vitamin D in Primary Hyperparathyroidism: Effects on Clinical, Biochemical, and Densitometric Presentation.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3443-51. PubMed ID: 26079779
[TBL] [Abstract][Full Text] [Related]
2. Low vitamin D levels have become less common in primary hyperparathyroidism.
Walker MD; Cong E; Lee JA; Kepley A; Zhang C; McMahon DJ; Bilezikian JP; Silverberg SJ
Osteoporos Int; 2015 Dec; 26(12):2837-43. PubMed ID: 26084258
[TBL] [Abstract][Full Text] [Related]
3. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism.
Walker MD; Saeed I; Lee JA; Zhang C; Hans D; Lang T; Silverberg SJ
Osteoporos Int; 2016 Oct; 27(10):3063-71. PubMed ID: 27198233
[TBL] [Abstract][Full Text] [Related]
4. Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture, and Stiffness in Primary Hyperparathyroidism.
Walker MD; Nishiyama KK; Zhou B; Cong E; Wang J; Lee JA; Kepley A; Zhang C; Guo XE; Silverberg SJ
J Clin Endocrinol Metab; 2016 Mar; 101(3):905-13. PubMed ID: 26745256
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
6. Association between serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism.
Walker MD; Cong E; Kepley A; Di Tullio MR; Rundek T; Homma S; Lee JA; Liu R; Young P; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2014 Feb; 99(2):671-80. PubMed ID: 24285686
[TBL] [Abstract][Full Text] [Related]
7. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism.
Lee JH; Kim JH; Hong AR; Kim SW; Shin CS
Osteoporos Int; 2017 May; 28(5):1667-1674. PubMed ID: 28175978
[TBL] [Abstract][Full Text] [Related]
8. Impact of 25-hydroxyvitamin D deficiency on perioperative parathyroid hormone kinetics and results in patients with primary hyperparathyroidism.
Untch BR; Barfield ME; Dar M; Dixit D; Leight GS; Olson JA
Surgery; 2007 Dec; 142(6):1022-6. PubMed ID: 18063090
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults.
Sayed-Hassan R; Abazid N; Koudsi A; Alourfi Z
Arch Osteoporos; 2016; 11():18. PubMed ID: 27126333
[TBL] [Abstract][Full Text] [Related]
10. Impact of vitamin D deficiency on the clinical and biochemical phenotype in women with sporadic primary hyperparathyroidism.
Viccica G; Cetani F; Vignali E; Miccoli M; Marcocci C
Endocrine; 2017 Jan; 55(1):256-265. PubMed ID: 27033542
[TBL] [Abstract][Full Text] [Related]
11. Seasonal Variability in Vitamin D Levels No Longer Detectable in Primary Hyperparathyroidism.
Cong E; Walker MD; Kepley A; Zhang C; McMahon DJ; Silverberg SJ
J Clin Endocrinol Metab; 2015 Sep; 100(9):3452-9. PubMed ID: 26120793
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D deficiency influences histomorphometric features of bone in primary hyperparathyroidism.
Stein EM; Dempster DW; Udesky J; Zhou H; Bilezikian JP; Shane E; Silverberg SJ
Bone; 2011 Mar; 48(3):557-61. PubMed ID: 20950725
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism.
Moosgaard B; Christensen SE; Vestergaard P; Heickendorff L; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2008 May; 68(5):707-15. PubMed ID: 17980013
[TBL] [Abstract][Full Text] [Related]
14. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis.
Sahota O; Mundey MK; San P; Godber IM; Lawson N; Hosking DJ
Bone; 2004 Jul; 35(1):312-9. PubMed ID: 15207772
[TBL] [Abstract][Full Text] [Related]
15. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
[TBL] [Abstract][Full Text] [Related]
16. Predictors and relationships of serum 25 hydroxyvitamin D concentration with bone turnover markers, bone mineral density, and vitamin D receptor genotype in Emirati women.
Saadi HF; Nagelkerke N; Benedict S; Qazaq HS; Zilahi E; Mohamadiyeh MK; Al-Suhaili AI
Bone; 2006 Nov; 39(5):1136-1143. PubMed ID: 16814623
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D status and PTH in young men: a cross-sectional study on associations with bone mineral density, body composition and glucose metabolism.
Frost M; Abrahamsen B; Nielsen TL; Hagen C; Andersen M; Brixen K
Clin Endocrinol (Oxf); 2010 Nov; 73(5):573-80. PubMed ID: 20718769
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
19. Serum PTH reference values established by an automated third-generation assay in vitamin D-replete subjects with normal renal function: consequences of diagnosing primary hyperparathyroidism and the classification of dialysis patients.
Souberbielle JC; Massart C; Brailly-Tabard S; Cormier C; Cavalier E; Delanaye P; Chanson P
Eur J Endocrinol; 2016 Mar; 174(3):315-23. PubMed ID: 26628583
[TBL] [Abstract][Full Text] [Related]
20. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
